Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women
- 198 Downloads
Although many hypotheses regarding the pathogenesis of polycystic ovary syndrome (PCOS) have been generated, genetic studies have not identified specific genes that play a role in PCOS etiopathogenesis. This study aimed to investigate the relationship between TGF-β1 gene polymorphism and PCOS in Koreans.
A total of 51 Korean women with PCOS and 69 healthy women were enrolled. We analyzed 4 single nucleotide polymorphisms (SNPs) of the TGF-β1 gene (rs11466313, rs1800469, rs2317130, and rs4803457). We also analyzed laboratory measurements, such as free testosterone, glucose, and cholesterol.
The frequencies of rs1800469T allele negativity, rs4803457T allele negativity, the rs1800469CC genotype, and the rs4803457CC genotype showed positive associations with PCOS (P = 0.003, P = 0.027, P = 0.009, and P=0.031, respectively), whereas the haplotypes rs1800469C–rs4803457T and rs1800469T–rs4803457T showed negative associations with PCOS. A strong protective effect of the “rs1800469CT–rs4803457TT” combination (OR = 0.09) and a strong risk effect of “rs1800469CC–rs4803457CC” (OR = 6.23) for PCOS were observed. The rs1800469C/T and rs2317130C/T SNPs exhibited associations with several laboratory measurements with various levels of significance.
The results demonstrated an association of TGF-β1 gene polymorphisms with the development and/or characteristics of PCOS in the Korean population.
KeywordsPolycystic ovary syndrome TGF-β1 gene polymorphism Testosterone Korean
Compliance with ethical standards
This study complied with ethical standards. Study design, including subject enrollment and informed consent, were approved by the Institutional Review Board of Seoul National University Boramae Medical Center (16-2015-144).
Conflict of interest
The authors declare that they have no conflict of interest.
No funding to report for this submission.
- 3.Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study. Genet Test Mol Biomarkers. 2014;18:605–9. doi: 10.1089/gtmb.2014.0151.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Raja-Khan N, Kunselman AR, Demers LM, Ewens KG, Spielman RS, Legro RS. A variant in the fibrillin-3 gene is associated with TGF-beta and inhibin B levels in women with polycystic ovary syndrome. Fertil Steril. 2010;94:2916–9. doi: 10.1016/j.fertnstert.2010.05.047.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Kim JJ, Choi YM, Cho YM, Hong MA, Chae SJ, Hwang KR, Hwang SS, Yoon SH, Moon SY. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clin Endocrinol (Oxf). 2012;77:439–45; doi: 10.1111/j.1365-2265.2012.04389.x.
- 22.Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011:CD007506; doi: 10.1002/14651858.CD007506.pub3.